Literature DB >> 2556616

A new alcohol antagonist: phaclofen.

A M Allan1, R A Harris.   

Abstract

The ability of the GABA(B) receptor antagonist, phaclofen to alter behavioral effects of ethanol was evaluated by loss of righting reflex (sleep time), motor incoordination (bar holding), spontaneous locomotion (open field activity) and hypothermia. Pretreatment with phaclofen significantly decreased the effects of ethanol on motor incoordination, locomotor activity and hypothermia. However, phaclofen had no effect on either pentobarbitalor diazepam-induced motor incoordination. Phaclofen slightly increased the ED50 for loss of the righting reflex but did not alter either the duration of reflex loss produced by ethanol or blood ethanol levels at awakening. Our results suggest phaclofen is rapidly inactivated resulting in difficulty in observing antagonism of long duration ethanol effects. These findings suggest that the GABA(B) system may play a role in mediating several important actions of ethanol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556616     DOI: 10.1016/0024-3205(89)90516-x

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  Do GABAB receptors have a role in causing behavioural hyperexcitability, both during ethanol withdrawal and in naive mice?

Authors:  A J Mead; H J Little
Journal:  Psychopharmacology (Berl)       Date:  1995-01       Impact factor: 4.530

2.  The role of GABAB receptors in mediating the stimulatory effects of ethanol in mice.

Authors:  R E Humeniuk; J M White; J Ong
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

3.  Effects of combining ethanol (EtOH) with gamma-hydroxybutyrate (GHB) on the discriminative stimulus, locomotor, and motor-impairing functions of GHB in mice.

Authors:  Charles D Cook; Laura Biddlestone; Andrew Coop; Patrick M Beardsley
Journal:  Psychopharmacology (Berl)       Date:  2006-02-02       Impact factor: 4.530

4.  Decreased GABABR expression and increased neuronal cell death in developing rat brain after PTZ-induced seizure.

Authors:  Muhammad Imran Naseer; Ikram Ullah; Mohammed H Al-Qahtani; Sajjad Karim; Najeeb Ullah; Shakeel Ahmed Ansari; Myeong Ok Kim; Fehmida Bibi
Journal:  Neurol Sci       Date:  2012-04-07       Impact factor: 3.307

5.  Neuroprotective role of a brain-enriched tyrosine phosphatase, STEP, in focal cerebral ischemia.

Authors:  Ishani Deb; Namratta Manhas; Ranjana Poddar; Sathyanarayanan Rajagopal; Andrea M Allan; Paul J Lombroso; Gary A Rosenberg; Eduardo Candelario-Jalil; Surojit Paul
Journal:  J Neurosci       Date:  2013-11-06       Impact factor: 6.167

6.  Administration of neurotoxic doses of MDMA reduces sensitivity to ethanol and increases GAT-1 immunoreactivity in mice striatum.

Authors:  María Izco; Maria Dolores Gutierrez-Lopez; Ivanny Marchant; Esther O'Shea; Maria Isabel Colado
Journal:  Psychopharmacology (Berl)       Date:  2009-10-20       Impact factor: 4.530

7.  Gamma-aminobutyric acid B receptor 1 mediates behavior-impairing actions of alcohol in Drosophila: adult RNA interference and pharmacological evidence.

Authors:  Svetlana Dzitoyeva; Nikola Dimitrijevic; Hari Manev
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-11       Impact factor: 11.205

8.  Interactions of intracerebroventricular pertussis toxin treatment with the ataxic and hypothermic effects of ethanol.

Authors:  M J Durcan; R G Lister; P F Morgan; M Linnoila
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-08       Impact factor: 3.000

9.  Effects of ethanol and GABAB drugs on working memory in C57BL/6J and DBA/2J mice.

Authors:  T Escher; G Mittleman
Journal:  Psychopharmacology (Berl)       Date:  2004-04-03       Impact factor: 4.530

10.  GABA(B) receptor agonists reduce operant ethanol self-administration and enhance ethanol sedation in C57BL/6J mice.

Authors:  Joyce Besheer; Veronique Lepoutre; Clyde W Hodge
Journal:  Psychopharmacology (Berl)       Date:  2004-02-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.